| 1 | Nature Reviews Drug Discovery | 159.2 | 99th | Q1 | SCIE | – | No |
| 2 | Trends in Pharmacological Sciences | 32.4 | 99th | Q1 | SCIE | – | No |
| 3 | Annual Review of Pharmacology and Toxicology | 29.5 | 99th | Q1 | SCIE | – | No |
| 4 | Drug Resistance Updates | 29.1 | 98th | Q1 | SCIE | – | No |
| 5 | Medicinal Research Reviews | 29.1 | 98th | Q1 | SCIE | – | No |
| 6 | Pharmacology and Therapeutics | 28.3 | 98th | Q1 | SCIE | – | No |
| 7 | Pharmacological Reviews | 25.9 | 98th | Q1 | SCIE | – | No |
| 8 | Asian Journal of Pharmaceutical Sciences | 20.5 | 97th | Q1 | SCIE | – | Yes |
| 9 | Pharmacological Research | 19.1 | 97th | Q1 | SCIE | – | Yes |
| 10 | Molecular Therapy | 17.9 | 97th | Q1 | SCIE | – | No |
| 11 | Acta Pharmacologica Sinica | 17.7 | 96th | Q1 | SCIE | – | No |
| 12 | Drug Discovery Today | 16.8 | 96th | Q1 | SCIE | – | No |
| 13 | Journal for ImmunoTherapy of Cancer | 16.6 | 96th | Q1 | SCIE | – | Yes |
| 14 | Biomedicine and Pharmacotherapy | 15.9 | 95th | Q1 | SCIE | – | Yes |
| 15 | Neuropsychopharmacology | 15.7 | 95th | Q1 | SCIE | – | No |
| 16 | Phytotherapy Research | 14.5 | 95th | Q1 | SCIE | – | No |
| 17 | BioDrugs | 13.8 | 94th | Q1 | SCIE | – | No |
| 18 | Cell Chemical Biology | 13.6 | 94th | Q1 | SCIE | – | No |
| 19 | British Journal of Pharmacology | 13.5 | 94th | Q1 | SCIE | – | No |
| 20 | Chinese Herbal Medicines | 13.5 | 94th | Q1 | ESCI | – | Yes |
| 21 | European Neuropsychopharmacology | 13.2 | 93th | Q1 | SCIE | – | No |
| 22 | Phytomedicine | 13.2 | 93th | Q1 | SCIE | – | No |
| 23 | Neurotherapeutics | 12.6 | 93th | Q1 | SCIE | – | Yes |
| 24 | Apoptosis | 12.4 | 92th | Q1 | SCIE | – | No |
| 25 | Pharmaceutical Biology | 12.4 | 92th | Q1 | SCIE | – | Yes |
| 26 | Current Opinion in Pharmacology | 12.2 | 92th | Q1 | SCIE | – | No |
| 27 | Cellular and Molecular Life Sciences | 12 | 91th | Q1 | SCIE | – | Yes |
| 28 | Journal of Enzyme Inhibition and Medicinal Chemistry | 11.9 | 91th | Q1 | SCIE | – | Yes |
| 29 | NEJM Evidence | 11.7 | 91th | Q1 | ESCI | – | No |
| 30 | Medicine in Drug Discovery | 11.5 | 91th | Q1 | – | – | Yes |
| 31 | Current Neuropharmacology | 11.4 | 90th | Q1 | SCIE | – | No |
| 32 | Journal of Ethnopharmacology | 11.2 | 90th | Q1 | SCIE | – | No |
| 33 | European Journal of Medicinal Chemistry | 10.8 | 90th | Q1 | SCIE | – | No |
| 34 | Chinese Medicine (United Kingdom) | 10.4 | 89th | Q1 | SCIE | – | Yes |
| 35 | Journal of Psychopharmacology | 10.3 | 89th | Q1 | SCIE | – | No |
| 36 | Molecular Diagnosis and Therapy | 10 | 89th | Q1 | SCIE | – | No |
| 37 | Clinical Pharmacology and Therapeutics | 9.9 | 88th | Q1 | SCIE | – | No |
| 38 | Expert Review of Vaccines | 9.9 | 88th | Q1 | SCIE | – | Yes |
| 39 | Journal of Food Biochemistry | 9.9 | 88th | Q1 | SCIE | – | No |
| 40 | npj Vaccines | 9.8 | 87th | Q1 | SCIE | – | Yes |
| 41 | Frontiers in Pharmacology | 9.5 | 87th | Q1 | SCIE | – | Yes |
| 42 | Inflammation Research | 9.5 | 87th | Q1 | SCIE | – | No |
| 43 | Biochemical Pharmacology | 9.3 | 87th | Q1 | SCIE | – | No |
| 44 | Intelligent Pharmacy | 9.1 | 86th | Q1 | – | – | Yes |
| 45 | Cardiovascular Drugs and Therapy | 9 | 86th | Q1 | SCIE | – | No |
| 46 | Natural Products and Bioprospecting | 9 | 86th | Q1 | ESCI | – | Yes |
| 47 | Altex | 8.9 | 85th | Q1 | SCIE | – | Yes |
| 48 | Journal of Pharmacy and Pharmaceutical Sciences | 8.8 | 85th | Q1 | SCIE | – | Yes |
| 49 | Pharmaceutical Research | 8.7 | 85th | Q1 | SCIE | – | No |
| 50 | Inflammopharmacology | 8.7 | 84th | Q1 | SCIE | – | No |
| 51 | EXCLI Journal | 8.6 | 84th | Q1 | SCIE | – | Yes |
| 52 | Expert Opinion on Therapeutic Targets | 8.6 | 84th | Q1 | SCIE | – | No |
| 53 | PharmacoEconomics | 8.5 | 83th | Q1 | SCIE, SSCI | A | No |
| 54 | CNS Neuroscience and Therapeutics | 8.5 | 83th | Q1 | SCIE | – | Yes |
| 55 | Expert Opinion on Investigational Drugs | 8.5 | 83th | Q1 | SCIE | – | No |
| 56 | Cancer Biology and Therapy | 8.4 | 83th | Q1 | SCIE | – | Yes |
| 57 | Drug Safety | 8.4 | 82th | Q1 | SCIE | – | No |
| 58 | Pharmaceutical Medicine | 8.4 | 82th | Q1 | ESCI | – | No |
| 59 | Expert Opinion on Therapeutic Patents | 8.3 | 82th | Q1 | SCIE | – | No |
| 60 | International Journal of Neuropsychopharmacology | 8.3 | 81th | Q1 | SCIE | – | Yes |
| 61 | Saudi Pharmaceutical Journal | 8.2 | 81th | Q1 | SCIE | – | Yes |
| 62 | Neuropharmacology | 8.1 | 81th | Q1 | SCIE | – | No |
| 63 | Environmental Toxicology and Pharmacology | 8.1 | 80th | Q1 | SCIE | – | No |
| 64 | International Immunopharmacology | 8.1 | 80th | Q1 | SCIE | – | No |
| 65 | Antimicrobial Agents and Chemotherapy | 8 | 80th | Q1 | SCIE | – | No |
| 66 | Current Molecular Pharmacology | 7.8 | 80th | Q1 | SCIE | – | No |
| 67 | Antiviral Research | 7.8 | 79th | Q1 | SCIE | – | No |
| 68 | Psychopharmacology | 7.8 | 79th | Q1 | SCIE | – | No |
| 69 | Vaccines | 7.7 | 79th | Q1 | SCIE | – | Yes |
| 70 | Cannabis and Cannabinoid Research | 7.6 | 78th | Q1 | SCIE | – | No |
| 71 | Clinical Pharmacokinetics | 7.6 | 78th | Q1 | SCIE | – | No |
| 72 | European Journal of Pharmacology | 7.6 | 78th | Q1 | SCIE | – | No |
| 73 | Mini-Reviews in Medicinal Chemistry | 7.5 | 77th | Q1 | SCIE | – | No |
| 74 | Human Vaccines and Immunotherapeutics | 7.4 | 77th | Q1 | SCIE | – | Yes |
| 75 | Open Medicinal Chemistry Journal | 7.3 | 77th | Q1 | – | – | No |
| 76 | British Journal of Clinical Pharmacology | 7.3 | 76th | Q1 | SCIE | – | No |
| 77 | CNS and Neurological Disorders - Drug Targets | 7.3 | 76th | Q1 | SCIE | – | No |
| 78 | Pharmacological Reports | 7.2 | 76th | Q1 | SCIE | – | No |
| 79 | Skin Pharmacology and Physiology | 7 | 76th | Q1 | SCIE | – | No |
| 80 | Bioconjugate Chemistry | 7 | 75th | Q1 | SCIE | – | No |
| 81 | Drug Design, Development and Therapy | 6.9 | 75th | Q1 | SCIE | – | Yes |
| 82 | Drug Metabolism and Disposition | 6.8 | 75th | Q1 | SCIE | – | No |
| 83 | Anti-Cancer Agents in Medicinal Chemistry | 6.7 | 74th | Q2 | SCIE | – | No |
| 84 | Journal of Pharmacy and Pharmacology | 6.7 | 74th | Q2 | SCIE | – | No |
| 85 | Profiles of Drug Substances, Excipients and Related Methodology | 6.7 | 74th | Q2 | – | – | No |
| 86 | Drug and Chemical Toxicology | 6.6 | 73th | Q2 | SCIE | – | No |
| 87 | Journal of Antimicrobial Chemotherapy | 6.6 | 73th | Q2 | SCIE | – | No |
| 88 | Expert Opinion on Biological Therapy | 6.5 | 73th | Q2 | SCIE | – | No |
| 89 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 6.5 | 73th | Q2 | SCIE | – | No |
| 90 | Current Medicinal Chemistry | 6.5 | 72th | Q2 | SCIE | – | No |
| 91 | Drug and Alcohol Dependence | 6.5 | 72th | Q2 | SCIE, SSCI | – | No |
| 92 | Vascular Pharmacology | 6.5 | 72th | Q2 | SCIE | – | No |
| 93 | Biomolecules and Therapeutics | 6.4 | 71th | Q2 | SCIE | – | No |
| 94 | Frontiers in Drug Delivery | 6.4 | 71th | Q2 | ESCI | – | Yes |
| 95 | Journal of Neuroimmune Pharmacology | 6.4 | 71th | Q2 | SCIE | – | No |
| 96 | Journal of Natural Products | 6.3 | 70th | Q2 | SCIE | – | No |
| 97 | Progress in Medicinal Chemistry | 6.3 | 70th | Q2 | – | – | No |
| 98 | Toxicology and Applied Pharmacology | 6.2 | 70th | Q2 | SCIE | – | No |
| 99 | Cardiovascular Therapeutics | 6.1 | 69th | Q2 | SCIE | – | Yes |
| 100 | Chemical Biology and Drug Design | 6.1 | 69th | Q2 | SCIE | – | No |